Stock AFMD AFFIMED N.V.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Affimed N.V.

Equities

AFMD

NL0015001ZQ0

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-06-25 EDT 		5-day change 1st Jan Change
5.72 USD -3.54% Intraday chart for Affimed N.V. -5.45% -8.48%
06-12 Transcript : Affimed N.V., Q1 2024 Earnings Call, Jun 12, 2024
06-12 Affimed N.V. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
AFFIMED N.V. Stock Affimed N.V.
 87.1M - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 122B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 116B
ARGENX SE Stock argenx SE
 27.03B -
BIONTECH SE Stock BioNTech SE
 20.36B -
BEIGENE, LTD. Stock BeiGene, Ltd.
 15.91B -
  1. Stock Market
  2. Equities
  3. AFMD Stock
  4. Charts Affimed N.V.
  5. Sector Chart